Gut Microbiome essential for managing Type 2 Diabetes: Study Finds
A paper published in the journal Cell Host & Microbe examined the influence of the gut microbiome on the onset and management of type 2 diabetes. The review highlighted how the gut microbiome plays a critical role in the disease's development and its treatment strategies.
Type 2 diabetes is a multifaceted disorder, and scientists continue to investigate its underlying causes. There is growing interest in exploring how the gut microbiome influences the development of type 2 diabetes.
Type 2 diabetes frequently features insulin resistance, a condition where the body's cells do not effectively respond to insulin, a hormone produced by the beta cells in the pancreas.
The gut microbiome consists of microorganisms, including bacteria and viruses, present in the digestive tract. It plays a role in various systemic metabolic processes, and researchers are increasingly investigating how it contributes to the development of metabolic diseases.
Recent studies suggest that beta cell dysfunction involves several pathways, with the gut microbiome potentially playing a role in this process. The authors highlight that this insight has contributed to a more intricate understanding of the mechanisms behind diabetes.
The paper observes that the loss of many ancestral bacterial species over time has contributed to issues like metabolic diseases. This decline in gut microbiome diversity, likely linked to medication use and Western lifestyle, is hypothesized to be associated with the rise in type 2 diabetes.
Previous research has highlighted changes in the gut microbiome of individuals with type 2 diabetes, such as shifts in bacterial proportions and reduced species diversity. Factors like body responses, medications, and Western dietary habits can influence the gut microbiome, with oral antidiabetic drugs also impacting gut microbiota.
Additionally, the gut microbiome produces metabolic byproducts that influence various bodily functions, including immune responses and gut barrier integrity. For example, bile acids, which are metabolic products of the gut microbiome, are altered in individuals with type 2 diabetes.
Reference: Baars, D. P., Fondevila, M. F., Meijnikman, A. S., & Nieuwdorp, M. (2024). The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2024.07.017
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.